← Back to Clinical Trials
Recruiting NCT06750250

NCT06750250 The Effects of Aerobic Exercise During the Different Phases of Menstural Cycle

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT06750250
Status Recruiting
Phase
Sponsor Riphah International University
Condition Menstrual Cycle
Study Type INTERVENTIONAL
Enrollment 48 participants
Start Date 2024-12-15
Primary Completion 2025-04-15

Eligibility & Interventions

Sex Female only
Min Age 18 Years
Max Age 25 Years
Study Type INTERVENTIONAL
Interventions
Patient educationAerobics

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.

This trial targets 48 participants in total. It began in 2024-12-15 with a primary completion date of 2025-04-15.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

The menstrual cycle is a term to describe the sequence of events that occur in body as it prepares for the possibility of pregnancy each month. The average length of a menstrual cycle is 28 days. However a cycle can range in length from 21 days to about 35 days and still normal. The menstrual cycle is the time from the first day of your menstrual period until the first day of your next menstrual period. Every person's cycle is slightly different, but the process is the same. Menstruation is the monthly shedding of the lining of the uterus. Menstrual blood which is partly blood and partly tissue from the inside of the uterus flows from the uterus through the cervix and out of the body through vagina. Some people experience symptoms of menstruation and others don't. The intensity of these symptoms can also vary. The most common symptom is cramps. The cramping you feel in your pelvic area is your uterus contracting to release its lining. Menstrual cycle have four phases, menses phase (3 to 7 days of your periods), follicular phase (during the 10 to 14 days), ovulation phase (14 day if cycle is 28 days) and luteal phase (15 to 28 days).These will a Randomized control trial conduct on 42 participants. The data will be collected ffrom ladies gym and muscle work gym by using non-probability convenience sampling technique. The age between 18-25 years participants will perform the aerobic exercises during the different phases of menstrual cycle. A sample will be divided into two groups each group have 21 participants. The Group A control group will Education and Self-Management about health and fitness and perform the walk. Group B intervention group will be given the Aerobic exercise (cycling, treadmill and running). The participants assessed with Borg scale for rate perceived exertion, berg balance questionnaire use for performance test parameters and menstrual stress questionnaire use for behaviour. Data will be analyzed by using SPSS version 26.0.

Eligibility Criteria

Inclusion Criteria: * Age ranged 18 - 25 years * Physical active women * Weight 40 to 60 * Normal BMI ( 18 to 24) Exclusion Criteria: * Contraceptive pills * Perimenupause * Ammnorehic women * Pregnant female * Irregular menstrual cycle * Non-smokers to minimize confounding cardiovascular effects

Frequently Asked Questions

Who can join the NCT06750250 clinical trial?

This trial is open to female participants only, aged 18 Years or older, up to 25 Years, studying Menstrual Cycle. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT06750250 currently recruiting?

Yes, NCT06750250 is actively recruiting participants. Visit ClinicalTrials.gov or contact Riphah International University to inquire about joining.

Where is the NCT06750250 trial being conducted?

This trial is being conducted at Lahore, Pakistan.

Who is sponsoring the NCT06750250 clinical trial?

NCT06750250 is sponsored by Riphah International University. The trial plans to enroll 48 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology